Alltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the presentation of ...
The selection of this first target is a key step for the partnership between Medigene and WuXi Biologics, which aims to advance multiple TCR-TCEs over the next three years. The collaboration seeks to ...
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s ...
Copy number variants (CNVs) are genetic alterations where segments of chromosomes exhibit deviations from ... Japan. UT Health San Antonio is a world-class research university, ranking at the top 5% ...
Søren Tulstrup, President and CEO, Hansa Biopharma said, “We know that anti-AAV antibodies prevent up to 1 in 3 people from benefitting from gene therapies using AAV-vectors. 1-4 That’s why our ...
A cancer therapy that prompts the body's immune defenses against viruses and bacteria to attack tumors can make patients more vulnerable to heart attack and stroke.